{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:34:30Z","timestamp":1771684470930,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/maj.0b013e31805339ae","type":"journal-article","created":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T08:01:51Z","timestamp":1178524911000},"page":"290-292","source":"Crossref","is-referenced-by-count":25,"title":["Valproic Acid\u2013Induced Eosinophilic Pleural Effusion: A Case Report and Review of the Literature"],"prefix":"10.1016","volume":"333","author":[{"given":"Wendy","family":"Bullington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Sahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31805339ae_bb0010","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1378\/chest.110.5.1271","article-title":"Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study","volume":"110","author":"Rubins","year":"1996","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0272-5231(03)00125-4","article-title":"Drug induced pleural disease","volume":"25","author":"Huggins","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(81)90150-1","article-title":"Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease","volume":"1","author":"Rinne","year":"1981","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/106002809402800507","article-title":"Pleural effusion associated with chronic dantrolene administration","volume":"28","author":"Mahoney","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00007611-200093060-00016","article-title":"Pleural fluid and serum eosinophilia: association with fluoxetine hydrochloride","volume":"93","author":"Behnia","year":"2000","journal-title":"South Med J"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/rmed.1999.0701","article-title":"Eosinophilic pleural effusion associated due to gliclazide","volume":"94","author":"Tzanakis","year":"2000","journal-title":"Resp Med"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0040","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0012-3692(15)46503-1","article-title":"Isotretinoin-related eosinophilic pleural effusion [letter]","volume":"110","author":"Milleron BJ Valcke","year":"1996","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0045","first-page":"288","article-title":"Eosinophilic pleural effusion due to mesalamine: report of a rare occurrence","volume":"17","author":"Trisolini","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0050","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1056\/NEJM196812052792304","article-title":"Chronic nitrofurantoin pulmonary reactions: report of 5 cases","volume":"279","author":"Rosenow","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0055","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1378\/chest.103.3.955","article-title":"Eosinophilic pleuritis due to propylthiouracil","volume":"103","author":"Middleton","year":"1993","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0060","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.123.3.952","article-title":"Pleural effusion caused by prostaglandin E1 preparation","volume":"123","author":"Watanabe","year":"2002","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1526-4637.2003.03003.x","article-title":"Eosinophilic exudative pleural effusion after initiation of tizanidine treatment: a case report","volume":"4","author":"Moufarrege","year":"2003","journal-title":"Pain Medicine"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00007611-199508000-00023","article-title":"Eosinophilic pleural effusion associated with valproic acid administration","volume":"88","author":"Kaufman","year":"1995","journal-title":"South Med J"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0075","first-page":"613","article-title":"A case of eosinophilic pleural effusion secondary to valproic acid","volume":"117","author":"Shaib","year":"2000","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0080","first-page":"62","article-title":"Febrile pleuropericarditis during valproic acid treatment [in French]","volume":"30","author":"Tonnelier","year":"2001","journal-title":"Presse Med"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0085","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.SMJ.0000054223.79816.37","article-title":"Valproic acid-induced eosinophilic pleural effusion","volume":"96","author":"Kravetz","year":"2003","journal-title":"South Med J"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0090","first-page":"401","article-title":"Eosinophilic pleural effusion secondary to treatment with valproic acid","volume":"33","author":"Catalan","year":"2005","journal-title":"Actas Espanolas De Psiquiatria"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1345\/aph.10213","article-title":"Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H","volume":"35","author":"Debourdeau","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0272-5231(05)70080-0","article-title":"Drug-induced pleural disease","volume":"19","author":"Antony","year":"1998","journal-title":"Clin Chest Med"},{"key":"10.1097\/MAJ.0b013e31805339ae_bb0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method of estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915325714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915325714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T18:56:07Z","timestamp":1556391367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915325714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0002962915325714"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31805339ae","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}